Amantadine and Temporal Discrimination in Patients With Traumatic Brain Injury (TBI)

Summary

The study will explore the neurocognitive effect of four weeks of treatment with amantadine versus placebo in patients with traumatic brain injury using the Interval Bisection Timing Task. Approximately 16 individuals with traumatic brain injury are expected to participate in this study. Subject participation is expected to last up to 8 weeks with 16 study visits.

Timeline

Start

2009-01

Primary completion

2010-11

Completion

2010-11

Drugs

Indications